United States · FDA National Drug Code directory
BALVERSA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59676-030_41ec18e6-999d-f298-e063-6294a90aa2dc
- Product NDC
- 59676-030
- Form
- TABLET, FILM COATED
- Composition / generic term
- Erdafitinib
- Labeler
- Janssen Products LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190412
- Source listing expiry
- 20261231
Source-listed ingredients
- ERDAFITINIB — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (59676-030-56) / 56 TABLET, FILM COATED in 1 BOTTLE · 59676-030-56
- 1 BOTTLE in 1 CARTON (59676-030-84) / 84 TABLET, FILM COATED in 1 BOTTLE · 59676-030-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →